Cargando…
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes
Hepatitis B virus (HBV) infection remains a major public health concern worldwide with 240 million individuals chronically infected and at risk of developing cirrhosis and hepatocellular carcinoma. Current treatments rarely cure chronic hepatitis B infection, highlighting the need for new anti-HBV d...
Autores principales: | Guillot, Clément, Martel, Nora, Berby, Françoise, Bordes, Isabelle, Hantz, Olivier, Blanchet, Matthieu, Sureau, Camille, Vaillant, Andrew, Chemin, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479567/ https://www.ncbi.nlm.nih.gov/pubmed/28636622 http://dx.doi.org/10.1371/journal.pone.0179697 |
Ejemplares similares
-
Global transcriptomic profiling of microcystin-LR or -RR treated hepatocytes (HepaRG)
por: Biales, Adam D., et al.
Publicado: (2020) -
Evaluation of the impact of matrix stiffness on encapsulated HepaRG spheroids
por: Rebelo, Sofia P, et al.
Publicado: (2013) -
Evaluation of a novel PXR‐knockout in HepaRG(™) cells
por: Williamson, Beth, et al.
Publicado: (2016) -
Active Transport of Hepatotoxic Pyrrolizidine Alkaloids in HepaRG Cells
por: Enge, Anne-Margarethe, et al.
Publicado: (2021) -
Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells
por: Dubois-Pot-Schneider, Hélène, et al.
Publicado: (2022)